Corebridge Financial’s Cabaletta Bio CABA Stock Holding History

Corebridge Financial’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-21,981	Closed	-$30.4K	–	449
2025 Q1	$30.4K	Sell	21,981 -325	-1%	-$692	﹤0.01%	2835
2024 Q4	$50.6K	Sell	22,306 -1,403	-6%	-$4.93K	﹤0.01%	2826
2024 Q3	$112K	Buy	23,709 +580	+3%	+$3.36K	﹤0.01%	2565
2024 Q2	$173K	Buy	+23,129	New	+$283K	﹤0.01%	2283

Other funds holding CABA

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Corebridge Financial's CABA Position: Q2 2025 in Review

Corebridge Financial sold out of Cabaletta Bio (CABA) in Q2 2025, closing a stake of 21,981 shares — an estimated $30.4K sold.

Corebridge Financial first reported a position in CABA in Q2 2024 and held it in 4 quarters. The position peaked at $173K in Q2 2024. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2025.

Corebridge Financial reported no remaining Cabaletta Bio position as of Q2 2025 after selling out during the quarter.
Corebridge Financial sold 21,981 Cabaletta Bio shares in Q2 2025, an estimated $30.4K.
Corebridge Financial first reported a position in Cabaletta Bio in Q2 2024 and held it in 4 quarters.
Corebridge Financial's Cabaletta Bio position peaked at $173K in Q2 2024.
86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.